Fresenius SE & Co. KGaA (FSNUF)

Market Cap	30.77B +37.3%
Revenue (ttm)	26.33B +4.5%
Net Income	1.34B
EPS	2.38
Shares Out	n/a
PE Ratio	22.94
Forward PE	12.98
Dividend	1.13 (2.08%)
Ex-Dividend Date	May 23, 2025

Volume	900
Average Volume	594
Open	53.11
Previous Close	57.00
Day's Range	53.11 - 54.35
52-Week Range	37.73 - 58.16
Beta	0.90
RSI	57.71
Earnings Date	Feb 25, 2026

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1912
• Employees: 177,356
• Stock Exchange: OTCMKTS
• Ticker Symbol: FSNUF

Financial Performance

Financial numbers in EUR